Most cited papers from Anandaban Hospital

Anandaban Hospital

What are the most cited papers from Anandaban Hospital?

The most cited paper from Anandaban Hospital is "The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans" (David M. Tobin, Jay C. Vary, John P. Ray et al., 2010), with 541 citations. Next come "Comparative genomic and phylogeographic analysis of Mycobacterium leprae" (396) and "Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009–15" (176).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 15 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans David M. Tobin, Jay C. Vary, John P. Ray et al. · Cell Open access	Mar 2010	541
2	Comparative genomic and phylogeographic analysis of Mycobacterium leprae Marc Monot et al. · Nature Genetics Open access	Nov 2009	396
3	Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009–15 Emmanuelle Cambau et al. · Clinical Microbiology and Infection Open access138 authors	Mar 2018	176
4	Human TLR1 Deficiency Is Associated with Impaired Mycobacterial Signaling and Protection from Leprosy Reversal Reaction Elizabeth Ann Misch, Murdo Macdonald, Chaman Ranjit et al. · PLoS neglected tropical diseases Open access	6 May 2008	143
5	Development of an in-house loop-mediated isothermal amplification (LAMP) assay for detection of Mycobacterium tuberculosis and evaluation in sputum samples of Nepalese patients Basu Dev Pandey, Ajay Poudel, Tomoko Yoda et al. · Journal of Medical Microbiology	18 Mar 2008	127
6	Association of TNF, MBL, and VDR polymorphisms with leprosy phenotypes Bishwa R. Sapkota, Murdo Macdonald, William R. Berrington et al. · Human Immunology Open access	21 Jul 2010	107
7	ENLIST 1: An International Multi-centre Cross-sectional Study of the Clinical Features of Erythema Nodosum Leprosum Stephen L. Walker, Marivic F. Balagon, Joydeepa Darlong et al. · PLoS neglected tropical diseases Open access	9 Sep 2015	106
8	Dihydropteroate Synthase of Mycobacterium leprae and Dapsone Resistance Diana Lynn Williams, Laynette Spring, Eugene B. Harris et al. · Antimicrobial Agents and Chemotherapy Open access	Jun 2000	101
9	Common Polymorphisms in theNOD2Gene Region Are Associated with Leprosy and Its Reactive States William R. Berrington, Murdo Macdonald, Saraswoti Khadge et al. · The Journal of Infectious Diseases Open access	29 Mar 2010	97
10	Risk factors for erythema nodosum leprosum. Rakesh Manandhar, Joe Lemaster, PAUL W. ROCHE · PubMed	Sep 1999	89
11	T-Cell Regulation in Lepromatous Leprosy Kidist Bobosha, Louis Wilson, Krista E. van Meijgaarden et al. · PLoS neglected tropical diseases Open access	10 Apr 2014	86
12	Skin disease is common in rural Nepal: results of a point prevalence study SL Walker, Mahesh Shah, Virginia G. Hubbard et al. · British Journal of Dermatology	17 Aug 2007	85
13	Development of a whole blood assay to measure T cell responses to leprosy: a new tool for immuno-epidemiological field studies of leprosy immunity Rosemary E. Weir, Aric Morgan, Warwick J. Britton et al. · Journal of Immunological Methods	Nov 1994	77
14	Selection of Antigens and Development of Prototype Tests for Point-of-Care Leprosy Diagnosis Malcolm S. Duthie, Greg C. Ireton, Ganga V. Kanaujia et al. · Clinical and Vaccine Immunology Open access	21 Aug 2008	72
15	Risk factors for type-1 reactions in borderline leprosy patients PAUL W. ROCHE, W. J. Theuvenet, Warwick J. Britton · The Lancet	Sep 1991	69
16	Effective Treatment of Erythema Nodosum Leprosum with Thalidomide Is Associated with Immune Stimulation Patrick A. J. Haslett, PAUL W. ROCHE, Cynthia Ruth Butlin et al. · The Journal of Infectious Diseases Open access	16 Nov 2005	68
17	Diagnosis and Treatment of Leprosy Reactions in Integrated Services - The Patients' Perspective in Nepal Sonia F. Raffe, Min B. Thapa, Saraswoti Khadge et al. · PLoS neglected tropical diseases Open access	7 Mar 2013	64
18	Clinical outcomes in a randomized controlled study comparing azathioprine and prednisolone versus prednisolone alone in the treatment of severe leprosy type 1 reactions in Nepal Sharon Marlowe, Rachel A. Hawksworth, Cynthia Ruth Butlin et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene	20 Jul 2004	63
19	Longitudinal immune profiles in type 1 leprosy reactions in Bangladesh, Brazil, Ethiopia and Nepal Saraswoti Khadge et al. · BMC Infectious Diseases Open access	28 Oct 2015	63
20	A leprosy clinical severity scale for erythema nodosum leprosum: An international, multicentre validation study of the ENLIST ENL Severity Scale Stephen L. Walker et al. · PLoS neglected tropical diseases Open access	3 Jul 2017	55
21	Diagnosis and impact of neuropathic pain in leprosy patients in Nepal after completion of multidrug therapy Han Siong Toh, Jeni Maharjan, Ruby Thapa et al. · PLoS neglected tropical diseases Open access	2 Jul 2018	54
22	A Phase Two Randomised Controlled Double Blind Trial of High Dose Intravenous Methylprednisolone and Oral Prednisolone versus Intravenous Normal Saline and Oral Prednisolone in Individuals with Leprosy Type 1 Reactions and/or Nerve Function Impairment Stephen L. Walker, PETER G. NICHOLLS, Sushmita Dhakal et al. · PLoS neglected tropical diseases Open access	12 Apr 2011	46
23	A Postgenomic Approach to Identification ofMycobacterium leprae-Specific Peptides as T-Cell Reagents Hazel M. Dockrell, Shweta Brahmbhatt, Brian D. Robertson et al. · Infection and Immunity Open access	Oct 2000	45
24	Insights from animal models on the immunogenetics of leprosy: a review Linda B. Adams, Maria T. Peña, Rahul Sharma et al. · Memórias do Instituto Oswaldo Cruz Open access	Dec 2012	45
25	Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal Bijay Pandey, Kanchha Shrestha, Justin S. Lewis et al. · Tropical Doctor	Jul 2007	45
26	High levels of inflammatory cytokines are associated with poor clinical response to steroid treatment and recurrent episodes of type 1 reactions in leprosy Rakesh Manandhar, Nripesh Man Shrestha, Cynthia Ruth Butlin et al. · Clinical & Experimental Immunology Open access	May 2002	44
27	Delay in presentation and start of treatment in leprosy: experience in an out-patient clinic in Nepal LINDA M. ROBERTSON, PETER G. NICHOLLS, R Butlin · Leprosy Review Open access	2000	41
28	An assessment of the reported impact of the COVID-19 pandemic on leprosy services using an online survey of practitioners in leprosy referral centres Barbara de Barros, Saba M. Lambert, Edessa Negera et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene Open access	17 May 2021	40
29	Operational value of serological measurements in multibacillary leprosy patients: clinical and bacteriological correlates of antibody responses. PAUL W. ROCHE, Warwick J. Britton, S S Failbus et al. · PubMed	Sep 1990	40
30	Effectiveness of 32 versus 20 weeks of prednisolone in leprosy patients with recent nerve function impairment: A randomized controlled trial Inge Wagenaar, Erik B. Post, Wim Brandsma et al. · PLoS neglected tropical diseases Open access	4 Oct 2017	38
31	A preliminary investigation of the responsiveness or otherwise of patients and staff of a leprosy hospital to groups of shared or species specific antigens of mycobacteria J. L. Stanford, P. Nye, G.A.W. Rook et al. · Leprosy Review Open access	1981	38
32	Interventions for Stigma Reduction–Part 1: Theoretical Considerations Hugh Alistair Cross, Miriam L. Heijnders, Ajit K. Dalal et al. · Disability CBR & Inclusive Development Open access	15 Feb 2012	38
33	Whole blood RNA signatures in leprosy patients identify reversal reactions before clinical onset: a prospective, multicenter study Maria Tió‐Coma et al. · Scientific Reports Open access	29 Nov 2019	37
34	Serological monitoring of the response to chemotherapy in leprosy patients. PAUL W. ROCHE, Warwick J. Britton, S. S. Failbus et al. · PubMed	Mar 1993	37
35	Real-Time PCR and High-Resolution Melt Analysis for Rapid Detection of Mycobacterium leprae Drug Resistance Mutations and Strain Types Wei Li, Masanori Matsuoka, Masanori Kai et al. · Journal of Clinical Microbiology Open access	15 Dec 2011	37
36	Use of a whole blood assay to evaluatein vitroT cell responses to new leprosy skin test antigens in leprosy patients and healthy subjects Rosemary E. Weir, Patrick J. Brennan, Cynthia Ruth Butlin et al. · Clinical & Experimental Immunology Open access	May 1999	37
37	Identification of a systemic interferon-γ inducible antimicrobial gene signature in leprosy patients undergoing reversal reaction Rosane M. B. Teles, Jing Nan Lu, Maria Tió‐Coma et al. · PLoS neglected tropical diseases Open access	10 Oct 2019	32
38	Opening a Can of Worms: Leprosy Reactions and Complicit Soil-Transmitted Helminths Deanna A. Hagge, Pawan Parajuli, Chhatra B. Kunwar et al. · EBioMedicine Open access	Sep 2017	32
39	Development and evaluation of a novel multiple-primer PCR amplification refractory mutation system for the rapid detection of mutations conferring rifampicin resistance in codon 425 of the rpoB gene of Mycobacterium leprae Bishwa R. Sapkota, Chaman Ranjit, Kapil Dev Neupane et al. · Journal of Medical Microbiology	17 Jan 2008	32
40	Tibialis posterior transfer for the correction of foot drop in leprosy. Long-term outcome. Deydianne da Silva Soares · PubMed	1996	30
41	TIBIALIS POSTERIOR TRANSFER FOR THE CORRECTION OF FOOT DROP IN LEPROSY Deydianne da Silva Soares · Journal of Bone and Joint Surgery - British Volume	1996	29
42	Human Beta-Defensin 3 Is Up-Regulated in Cutaneous Leprosy Type 1 Reactions Anna L. Cogen, Stephen L. Walker, Chrissy h. Roberts et al. · PLoS neglected tropical diseases Open access	Nov 2012	29
43	Risk factors for type 1 reactions in leprosy. PAUL W. ROCHE, J Le Master, Cynthia Ruth Butlin · PubMed	Dec 1997	28
44	Genetic Variation in Toll-Interacting Protein Is Associated With Leprosy Susceptibility and Cutaneous Expression of Interleukin 1 Receptor Antagonist Javeed Ali Shah, William R. Berrington, Jay C. Vary et al. · The Journal of Infectious Diseases Open access	26 Nov 2015	28
45	Interventions for Stigma Reduction – Part 2: Practical Applications Hugh Alistair Cross, Miriam L. Heijnders, Ajit K. Dalal et al. · Disability CBR & Inclusive Development Open access	15 Feb 2012	27
46	Mycobacterium leprae virulence-associated peptides are indicators of exposure to M. leprae in Brazil, Ethiopia and Nepal Kidist Bobosha, Sheila Tuyet Tang, Jolien J. van der Ploeg-van Schip et al. · Memórias do Instituto Oswaldo Cruz Open access	Dec 2012	23
47	Rapid method for diagnosis of leprosy by measurements of antibodies to the M. leprae 35-kDa protein: comparison with PGL-I antibodies detected by ELISA and "dipstick" methods. PAUL W. ROCHE, S S Failbus, Warwick J. Britton et al. · PubMed	Sep 1999	23
48	Methotrexate and prednisolone study in erythema nodosum leprosum (MaPs in ENL) protocol: a double-blind randomised clinical trial Barbara de Barros, Saba M. Lambert, Mahesh Shah et al. · BMJ Open Open access	Nov 2020	21
49	Exploratory urinary metabolomics of type 1 leprosy reactions Oleg A. Mayboroda, Anouk van Hooij, Rico J. E. Derks et al. · International Journal of Infectious Diseases Open access	27 Feb 2016	21
50	A method for rapid detection of rifampicin-resistant isolates ofMycobacterium leprae Nadine Honoré, PAUL W. ROCHE, Jacques H.E. Grosset et al. · Leprosy Review Open access	2001	19

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.